Melanoma treatment guided by a panel of microRNA biomarkers

por Stark, Mitchell S
Publicado 2017

Current Trends in Circulating Biomarkers for Melanoma Detection

por Huang, Nancy, Lee, Katie J., Stark, Mitchell S.
Publicado 2022

On Naevi and Melanomas: Two Sides of the Same Coin?

por Lee, Katie J., Janda, Monika, Stark, Mitchell S., Sturm, Richard A., Soyer, H. Peter
Publicado 2021

SiDCoN: A Tool to Aid Scoring of DNA Copy Number Changes in SNP Chip Data

por Nancarrow, Derek J., Handoko, Herlina Y., Stark, Mitchell S., Whiteman, David C., Hayward, Nicholas K.
Publicado 2007

Circulating Biomarkers for Early Stage Non-Small Cell Lung Carcinoma Detection: Supplementation to Low‐Dose Computed Tomography

por Kan, Chin Fung Kelvin, Unis, Graham D., Li, Luke Z., Gunn, Susan, Li, Li, Soyer, H. Peter, Stark, Mitchell S.
Publicado 2021

Cross-Platform Array Screening Identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as Genes Frequently Silenced by Methylation in Melanoma

por Bonazzi, Vanessa F., Nancarrow, Derek J., Stark, Mitchell S., Moser, Ralf J., Boyle, Glen M., Aoude, Lauren G., Schmidt, Christopher, Hayward, Nicholas K.
Publicado 2011

The ‘melanoma-enriched’ microRNA miR-4731-5p acts as a tumour suppressor

por Stark, Mitchell S., Tom, Lisa N., Boyle, Glen M., Bonazzi, Vanessa F., Soyer, H. Peter, Herington, Adrian C., Pollock, Pamela M., Hayward, Nicholas K.
Publicado 2016

The Future of Precision Prevention for Advanced Melanoma

por Lee, Katie J., Betz-Stablein, Brigid, Stark, Mitchell S., Janda, Monika, McInerney-Leo, Aideen M., Caffery, Liam J., Gillespie, Nicole, Yanes, Tatiane, Soyer, H. Peter
Publicado 2022

Characterization of the Melanoma miRNAome by Deep Sequencing

por Stark, Mitchell S., Tyagi, Sonika, Nancarrow, Derek J., Boyle, Glen M., Cook, Anthony L., Whiteman, David C., Parsons, Peter G., Schmidt, Christopher, Sturm, Richard A., Hayward, Nicholas K.
Publicado 2010

miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma

por Stark, Mitchell S., Bonazzi, Vanessa F., Boyle, Glen M., Palmer, Jane M., Symmons, Judith, Lanagan, Catherine M., Schmidt, Christopher W., Herington, Adrian C., Ballotti, Robert, Pollock, Pamela M., Hayward, Nicholas K.
Publicado 2015

Smchd1 regulates a subset of autosomal genes subject to monoallelic expression in addition to being critical for X inactivation

por Mould, Arne W, Pang, Zhenyi, Pakusch, Miha, Tonks, Ian D, Stark, Mitchell, Carrie, Dianne, Mukhopadhyay, Pamela, Seidel, Annica, Ellis, Jonathan J, Deakin, Janine, Wakefield, Matthew J, Krause, Lutz, Blewitt, Marnie E, Kay, Graham F
Publicado 2013

Multiple interaction nodes define the postreplication repair response to UV‐induced DNA damage that is defective in melanomas and correlated with UV signature mutation load

por Pavey, Sandra, Pinder, Alex, Fernando, Winnie, D’Arcy, Nicholas, Matigian, Nicholas, Skalamera, Dubravka, Lê Cao, Kim‐Anh, Loo‐Oey, Dorothy, Hill, Michelle M., Stark, Mitchell, Kimlin, Michael, Burgess, Andrew, Cloonan, Nicole, Sturm, Richard A., Gabrielli, Brian
Publicado 2019

A Panel of Circulating MicroRNAs Detects Uveal Melanoma With High Precision

por Stark, Mitchell S., Gray, Elin S., Isaacs, Timothy, Chen, Fred K., Millward, Michael, McEvoy, Ashleigh, Zaenker, Pauline, Ziman, Melanie, Soyer, H. Peter, Glasson, William J., Warrier, Sunil K., Stark, Andrew L., Rolfe, Olivia J., Palmer, Jane M., Hayward, Nicholas K.
Publicado 2019

Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants

por Rayner, Jenna E., Duffy, David L., Smit, Darren J., Jagirdar, Kasturee, Lee, Katie J., De’Ambrosis, Brian, Smithers, B. Mark, McMeniman, Erin K., McInerney-Leo, Aideen M., Schaider, Helmut, Stark, Mitchell S., Soyer, H. Peter, Sturm, Richard A.
Publicado 2020

Distinct histone modifications denote early stress-induced drug tolerance in cancer

por Emran, Abdullah Al, Marzese, Diego M., Menon, Dinoop Ravindran, Stark, Mitchell S., Torrano, Joachim, Hammerlindl, Heinz, Zhang, Gao, Brafford, Patricia, Salomon, Matthew P., Nelson, Nellie, Hammerlindl, Sabrina, Gupta, Deepesh, Mills, Gordon B., Lu, Yiling, Sturm, Richard A., Flaherty, Keith, Hoon, Dave S. B., Gabrielli, Brian, Herlyn, Meenhard, Schaider, Helmut
Publicado 2017

Terahertz imaging of human skin pathologies using laser feedback interferometry with quantum cascade lasers

por Qi, Xiaoqiong, Bertling, Karl, Stark, Mitchell S., Taimre, Thomas, Kao, Yung-Ching, Lim, Yah Leng, Han, She, O’Brien, Blake, Collins, Angus, Walsh, Michael, Torniainen, Jari, Gillespie, Timothy, Donose, Bogdan C., Dean, Paul, Li, Lian He, Linfield, Edmund H., Davies, A. Giles, Indjin, Dragan, Soyer, H. Peter, Rakić, Aleksandar D.
Publicado 2023

The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis()

por Stark, Mitchell S., Klein, Kerenaftali, Weide, Benjamin, Haydu, Lauren E., Pflugfelder, Annette, Tang, Yue Hang, Palmer, Jane M., Whiteman, David C., Scolyer, Richard A., Mann, Graham J., Thompson, John F., Long, Georgina V., Barbour, Andrew P., Soyer, H. Peter, Garbe, Claus, Herington, Adrian, Pollock, Pamela M., Hayward, Nicholas K.
Publicado 2015

Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis

por Hendricks, William P. D., Zismann, Victoria, Sivaprakasam, Karthigayini, Legendre, Christophe, Poorman, Kelsey, Tembe, Waibhav, Perdigones, Nieves, Kiefer, Jeffrey, Liang, Winnie, DeLuca, Valerie, Stark, Mitchell, Ruhe, Alison, Froman, Roe, Duesbery, Nicholas S., Washington, Megan, Aldrich, Jessica, Neff, Mark W., Huentelman, Matthew J., Hayward, Nicholas, Brown, Kevin, Thamm, Douglas, Post, Gerald, Khanna, Chand, Davis, Barbara, Breen, Matthew, Sekulic, Alexander, Trent, Jeffrey M.
Publicado 2018

Frequent somatic MAP3K5 and MAP3K9 mutations in metastatic melanoma identified by exome sequencing

por Stark, Mitchell S, Woods, Susan L, Gartside, Michael G, Bonazzi, Vanessa F, Dutton-Regester, Ken, Aoude, Lauren G, Chow, Donald, Sereduk, Chris, Niemi, Natalie M, Tang, Nanyun, Ellis, Jonathan J, Reid, Jeffrey, Zismann, Victoria, Tyagi, Sonika, Muzny, Donna, Newsham, Irene, Wu, YuanQing, Palmer, Jane M, Pollak, Thomas, Youngkin, David, Brooks, Bradford R, Lanagan, Catherine, Schmidt, Christopher W, Kobe, Bostjan, MacKeigan, Jeffrey P, Yin, Hongwei, Brown, Kevin M, Gibbs, Richard, Trent, Jeffrey, Hayward, Nicholas K
Publicado 2011

POT1 loss-of-function variants predispose to familial melanoma

por Robles-Espinoza, Carla Daniela, Harland, Mark, Ramsay, Andrew J., Aoude, Lauren G., Quesada, Víctor, Ding, Zhihao, Pooley, Karen A., Pritchard, Antonia L., Tiffen, Jessamy C., Petljak, Mia, Palmer, Jane M., Symmons, Judith, Johansson, Peter, Stark, Mitchell S., Gartside, Michael G., Snowden, Helen, Montgomery, Grant W., Martin, Nicholas G., Liu, Jimmy Z., Choi, Jiyeon, Makowski, Matthew, Brown, Kevin M., Dunning, Alison M., Keane, Thomas M., López-Otín, Carlos, Gruis, Nelleke A., Hayward, Nicholas K., Bishop, D. Timothy, Newton-Bishop, Julia A., Adams, David J.
Publicado 2014